Buteyko Method for Asthmatic Children With Mouth Breathing

Not Applicable

Completed

• Conditions: Mouth Breathing; Asthma
• Interventions: Other: Buteyko Method

• Registration Number: NCT02724657
• Lead Sponsor: Universidade Federal do Rio Grande do Norte

Brief Summary

To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03
• Study First Submitted: 2016-03-07
• Study First Submitted QC: 2016-03-30
• Study First Posted: 2016-03-31
• Primary Completion: 2016-08
• Study Completion: 2016-10
• Status Verified: 2017-01
• Last Update Submitted: 2017-01-20
• Last Update Posted: 2017-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• Children from 7 up to 12 years old with asthma diagnose
• Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks.
• Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

Exclusion Criteria

• Children that are not able to perform some of the necessary procedures, give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Buteyko Method	Buteyko Method	Children will perform 6 sessions (twice a week) of treatment with the Buteyko Method.

Primary Outcome Measures

Name	Time	Method
Change in Sleep disturbance (questionnaire)	Baseline, three weeks later and six months after treatment	Sleep disturbance will be assessed by the sleep disturbance scale for children (SDSC).

Secondary Outcome Measures

Name	Time	Method
Change in spirometry (FVC, FEV1, FEV1/FVC, FEF25-75%, PEF)	Baseline, three weeks later and six months after treatment
Change in ventilometry (minute volume and vital capacity)	Baseline, three weeks later and six months after treatment	Minute volume and vital capacity (liters)
Number of hospitalizations	Through study completion, an average of three weeks and six months after treatment
Number of days off-school	During the three weeks of treatment

Trial Locations

Locations (1)

Universidade Federal do Rio Grande do Norte (UFRN); 🇧🇷 Natal, Rio Grande do Norte, Brazil